![Jeffrey James Roix](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey James Roix
Director/Board Member at Stingray Bio Ltd.
Jeffrey James Roix active positions
Companies | Position | Start | End |
---|---|---|---|
Stingray Bio Ltd.
![]() Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Stingray Bio Ltd. is a British biotechnology research company founded in 2020. The company is based in Brighton, UK. The company provides research services in the field of biotechnology. | Director/Board Member | 01/04/2021 | - |
o2h Ltd
![]() o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Private Equity Investor | 01/07/2020 | - |
Opal Therapeutics Ltd.
![]() Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opal Oncology Ltd. operates as a pharmaceutical company. It develops drugs for cancer. The company was founded in 2012 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 01/03/2021 | - |
Career history of Jeffrey James Roix
Former positions of Jeffrey James Roix
Companies | Position | Start | End |
---|---|---|---|
PhoreMost Ltd.
![]() PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Chief Operating Officer | 01/02/2015 | 01/04/2018 |
NeoPhore Ltd.
![]() NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Director/Board Member | - | - |
Chief Executive Officer | - | - |
Training of Jeffrey James Roix
Harvard Extension School | Undergraduate Degree |
Statistics
International
United Kingdom | 6 |
United States | 2 |
Operational
Director/Board Member | 3 |
Chief Executive Officer | 1 |
Private Equity Investor | 1 |
Sectoral
Commercial Services | 3 |
Health Technology | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 5 |
---|---|
NeoPhore Ltd.
![]() NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Commercial Services |
Stingray Bio Ltd.
![]() Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Stingray Bio Ltd. is a British biotechnology research company founded in 2020. The company is based in Brighton, UK. The company provides research services in the field of biotechnology. | Commercial Services |
o2h Ltd
![]() o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Finance |
PhoreMost Ltd.
![]() PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Opal Therapeutics Ltd.
![]() Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opal Oncology Ltd. operates as a pharmaceutical company. It develops drugs for cancer. The company was founded in 2012 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Jeffrey James Roix
- Experience